Scientific Certainty in a Time of Uncertainty: Predicting Vulnerability of Canada's First Nations to Pandemic H1N1/09
DOI:
https://doi.org/10.18584/iipj.2010.1.1.1Abstract
On June 11, 2009, the Director General of the World Health Organization, Dr. Margaret Chan, announced that the scientific evidence indicated that the criteria for an influenza pandemic had been met: pandemic H1N1/09 virus, the first in nearly 40 years, was officially upon us. The World Health Organization has estimated that as many as 2 billion or between 15 and 45 percent of the population globally will be infected by the H1N1/09 virus. Scientists and governments have been careful to walk a line between causing mass public fear and ensuring people take the risks seriously. The latest information indicates that the majority of individuals infected with the H1N1/09 virus thus far have suffered mild illness, although very severe and fatal illness have been observed in a small number of cases, even in young and healthy people (World Health Organization 2009c). There is no evidence to date that the virus has mutated to a more virulent or lethal form; however, as we enter the second wave of the pandemic, a significant number of people in countries across the world are susceptible to infection. Most importantly, certain subgroups have been categorized as high risk given the clinical evidence to date. One of these subgroups is Indigenous populations (World Health Organization 2009c).
Downloads
Published
Issue
Section
License
Copyright (c) 2010 Nicholas Spence, Jerry P. White
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
In keeping with IIPJ's Open Access policy, IIPJ has a shared approach to copyright. A shared approach means that authors do not have to waive all of their rights to the work published in IIPJ. By submitting to IIPJ, the author(s) grant(s) IIPJ the right to:
- Copy edit the article,
- Display the article in perpetuity, and
- Enforce the conditions of the Creative Commons license associated with the article.
All articles published in IIPJ carry the Creative Commons Attribution, Non-Commercial, No Derivatives license (click here for the human-readable summary and here for the legal code).
This means that the article can be copied or redistributed without written permission from the author(s) or IIPJ if the following conditions are met:
- IIPJ is appropriately credited as the original source. The reference should include the article's DOI (Digital Object Identifier), which helps us track the dissemination of articles published in IIPJ.
- The article is not being used for a commercial purpose. Users must be able to access the reprinted or republished article without paying any fee.
- The article is not altered from its original form. This means it cannot be edited, transformed, remixed, or truncated in any way. This policy protects our authors from having their work or intent misrepresented.
Any reprints, republications, or distributions that do not meet all of these conditions must be approved in writing by the author(s) of the article and IIPJ.
IIPJ will not grant permission to any publisher that requires authors or IIPJ to waive any of their rights to the article.
Authors who wish to reprint, republish, or distribute their article published in IIPJ for any commercial purpose must obtain written permission from IIPJ and provide appropriate attribution.
IIPJ will consider accepting articles that have been previously published. However, authors submitting articles of this nature must:
- Indicate that the article was previously published,
- Provide details of all previous publications (that is, source, publication date, format, etc.),
- Describe how their IIPJ submission differs from the original publication, and
- Provide written permission to republish the article from the copyright holder(s) if applicable.